Saber and co‐workers23 showed that COPD is not associated with the presence of KRAS mutations as observed in lung cancer, whereas presence of EGFR mutations was more frequent in non‐COPD as compared to COPD lung patients. Here, EGFR is linked to lung carcinoma.